XML 45 R30.htm IDEA: XBRL DOCUMENT
v3.24.4

SEGMENT AND GEOGRAPHIC AREA INFORMATION (Tables) | 12 Months Ended
--- | ---
Sep. 30, 2024
SEGMENT AND GEOGRAPHIC AREA INFORMATION |
Schedule of information regarding operations by segment | Information regarding operations by segment for the twelve- month period ended September 30, 2024 is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Therapeutic DNA | ​ | MDx Testing | ​ | DNA Tagging and | ​ | ​ | ​
​ |  | Production |  | Services |  | Security Products |  | Consolidated
Revenues: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Product revenues | ​ | $ | 560,000 | ​ | $ | — | ​ | $ | 514,813 | ​ | $ | 1,074,813
Service revenues | ​ |  | 335,354 | ​ | ​ | — | ​ | ​ | 703,323 | ​ | ​ | 1,038,677
Clinical laboratory service revenues | ​ |  | — | ​ | ​ | 1,330,850 | ​ | ​ | — | ​ | ​ | 1,330,850
Less intersegment revenues | ​ |  | — | ​ | ​ | (12,920) | ​ | ​ | — | ​ | ​ | (12,920)
Total revenues | ​ | $ | 895,354 | ​ | $ | 1,317,930 | ​ | $ | 1,218,136 | ​ | $ | 3,431,420
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Gross profit | ​ | $ | 678,166 | ​ | $ | (49,830) | ​ | $ | 388,543 | ​ | $ | 1,016,879
(Loss) income from segment operations (a) | ​ | $ | (4,789,268) | ​ | $ | (1,489,220) | ​ | $ | (2,551,983) | ​ | $ | (8,830,471)
​ Information regarding operations by segment for the twelve- month period ended September 30, 2023 is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Therapeutic DNA | ​ | MDx Testing | ​ | DNA Tagging and | ​ | ​ | ​
​ |  | Production |  | Services |  | Security Products |  | Consolidated
Revenues: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Product revenues | ​ | $ | 560,000 | ​ | $ | — | ​ | $ | 658,185 | ​ | $ | 1,218,185
Service revenues | ​ |  | 506,285 | ​ | ​ | — | ​ | ​ | 490,581 | ​ | ​ | 996,866
Clinical laboratory service revenues | ​ |  | — | ​ | ​ | 11,253,312 | ​ | ​ | — | ​ | ​ | 11,253,312
Less intersegment revenues | ​ |  | — | ​ | ​ | (100,920) | ​ | ​ | — | ​ | ​ | (100,920)
Total revenues | ​ | $ | 1,066,285 | ​ | $ | 11,152,392 | ​ | $ | 1,148,766 | ​ | $ | 13,367,443
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Gross profit | ​ | $ | 748,940 | ​ | $ | 4,409,186 | ​ | $ | 375,306 | ​ | $ | 5,533,432
(Loss) income from segment operations (a) | ​ | $ | (3,792,871) | ​ | $ | 1,206,652 | ​ | $ | (3,550,794) | ​ | $ | (6,137,013)
Schedule of reconciliation of segment loss from operations to corporate (loss) income | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30,
​ |  | 2024 | ​ | 2023
Loss from operations of reportable segments |  | $ | (8,830,471) |  | $ | (6,137,013)
General corporate expenses (b) | ​ |  | (5,194,294) | ​ |  | (4,816,277)
Interest income | ​ |  | 176,301 | ​ |  | 75,332
Unrealized gain on change in fair value of warrants classified as a liability | ​ | ​ | 9,430,000 | ​ | ​ | —
Unrealized loss on change in fair value of warrants classified as a liability - warrant modification | ​ | ​ | (394,000) | ​ | ​ | —
Transaction costs allocated to registered direct offering | ​ | ​ | (633,198) | ​ | ​ | 854,400
Transaction costs allocated to warrant liabilities | ​ | ​ | — | ​ | ​ | —
Loss on issuance of warrants | ​ | ​ | (1,633,767) | ​ | ​ | —
Other income (expense), net | ​ |  | (8,877) | ​ | $ | 642
Consolidated loss before provision for income taxes | ​ | $ | (7,088,306) | ​ | $ | (10,022,916)
| (a) | Segment operating loss consists of net sales less cost of sales, specifically identifiable research and development, and selling, general and administrative expenses.
| (b) | General corporate expenses consists of Selling, general and administrative expenses that are not specifically identifiable to a segment.
Schedule of net revenues by geographic location of customers | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended September 30,
​ |  | 2024 |  | 2023
Americas | ​ | $ | 2,269,826 | ​ | $ | 12,222,650
Europe | ​ |  | 172,368 | ​ | ​ | 258,355
Asia and other | ​ |  | 989,226 | ​ | ​ | 886,438
Total | ​ | $ | 3,431,420 | ​ | $ | 13,367,443
​

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration